Huaxia Eye Hospital Group Co.,Ltd.
SZSE:301267 주식 보고서
Huaxia Eye Hospital GroupLtd 과거 수익 실적 Huaxia Eye Hospital GroupLtd은 연평균 16.2%의 비율로 수입이 증가해 온 반면, Healthcare 산업은 수입이 증가했으며, 연간 2%였습니다. 매출은 연평균 11.4%의 비율로 증가했습니다. Huaxia Eye Hospital GroupLtd의 자기자본이익률은 9.1%이고 순이익률은 12.9%입니다.
주요 정보 Healthcare 산업 성장 7.0% 매출 성장률 11.4% 자기자본 수익률 9.1% 순이익 12.9% 최근 수익 업데이트 30 Sep 2024
최근 과거 실적 업데이트
Third quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.24 in 3Q 2023) Oct 29
Huaxia Eye Hospital Group Co.,Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Sep 30
Huaxia Eye Hospital GroupLtd's (SZSE:301267) Conservative Accounting Might Explain Soft Earnings Sep 04
Second quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.24 in 2Q 2023) Aug 29
Huaxia Eye Hospital Group Co.,Ltd. to Report First Half, 2024 Results on Aug 29, 2024 Jun 29
First quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 1Q 2023) Apr 26
모든 업데이트 표시
Investor sentiment improves as stock rises 17% Nov 08
Third quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.24 in 3Q 2023) Oct 29
Here's What's Concerning About Huaxia Eye Hospital GroupLtd's (SZSE:301267) Returns On Capital Oct 28
Investor sentiment deteriorates as stock falls 27% Oct 15
Huaxia Eye Hospital Group Co.,Ltd.'s (SZSE:301267) 43% Price Boost Is Out Of Tune With Earnings Sep 30
New minor risk - Share price stability Sep 30
Huaxia Eye Hospital Group Co.,Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Sep 30
Investor sentiment improves as stock rises 26% Sep 27
Huaxia Eye Hospital GroupLtd's (SZSE:301267) Conservative Accounting Might Explain Soft Earnings Sep 04
Second quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.24 in 2Q 2023) Aug 29
Does Huaxia Eye Hospital GroupLtd (SZSE:301267) Have A Healthy Balance Sheet? Aug 19
Huaxia Eye Hospital GroupLtd's (SZSE:301267) Dividend Is Being Reduced To CN¥0.11 Jul 12
Dividend of CN¥0.11 announced Jul 11
Huaxia Eye Hospital Group Co.,Ltd. Announces Final Cash Dividend of A Shares for 2023, Payable on 15 July 2024 Jul 10
Huaxia Eye Hospital Group Co.,Ltd. to Report First Half, 2024 Results on Aug 29, 2024 Jun 29
Huaxia Eye Hospital GroupLtd (SZSE:301267) Has Some Way To Go To Become A Multi-Bagger Jun 06
Consensus revenue estimates fall by 11% May 02
Analysts Just Shaved Their Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) Forecasts Dramatically May 01
Price target decreased by 11% to CN¥50.02 Apr 30
Huaxia Eye Hospital Group Co.,Ltd., Annual General Meeting, May 20, 2024 Apr 28 Huaxia Eye Hospital Group Co.,Ltd. Proposes Final Cash Dividend for 2023 Apr 27
First quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 1Q 2023) Apr 26
Huaxia Eye Hospital Group Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Mar 30
Huaxia Eye Hospital GroupLtd (SZSE:301267) Seems To Use Debt Rather Sparingly Feb 29
Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) announces an Equity Buyback for CNY 250 million worth of its shares. Jan 10 Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) announces an Equity Buyback for CNY 250 million worth of its shares. Jan 09
Huaxia Eye Hospital Group Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024 Dec 30
New minor risk - Dividend sustainability Dec 07
Now 20% undervalued Nov 09
New minor risk - Share price stability Oct 25
Now 22% undervalued after recent price drop Oct 25
Huaxia Eye Hospital Group Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023 Sep 30
Second quarter 2023 earnings released: EPS: CN¥0.70 (vs CN¥0.22 in 2Q 2022) Aug 30
Huaxia Eye Hospital Group Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on July 11, 2023 Jul 06
Huaxia Eye Hospital Group Co.,Ltd. Approves Final Cash Dividend for the Year 2022 May 19
First quarter 2023 earnings released: EPS: CN¥0.27 (vs CN¥0.24 in 1Q 2022) Apr 25
Huaxia Eye Hospital Group Co.,Ltd. Announces Executive Appointments Dec 13
Huaxia Eye Hospital GroupLtd 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역 SZSE:301267 수익, 비용 및 수입 (CNY Millions ) 날짜 수익 수익 G+A 비용 R&D 비용 30 Sep 24 4,092 529 1,076 61 30 Jun 24 4,070 577 1,054 66 31 Mar 24 4,061 672 1,027 72 31 Dec 23 4,013 666 998 70 30 Sep 23 3,813 674 933 75 30 Jun 23 3,648 632 867 69 31 Mar 23 3,355 552 786 56 01 Jan 23 3,233 514 762 49 30 Sep 22 3,297 516 762 47 01 Jan 22 3,064 455 717 25 30 Sep 21 2,998 445 675 22 31 Dec 20 2,515 334 591 20 31 Dec 19 2,456 218 682 19 31 Dec 18 2,146 164 621 14 31 Dec 17 1,543 78 495 11
양질의 수익: 301267 은 높은 수익 을 보유하고 있습니다.
이익 마진 증가: 301267 의 현재 순이익 이익률 (12.9%) 작년보다 낮습니다 (17.7%).
과거 수익 성장 분석
수익추이: 301267 의 수입은 지난 5년 동안 매년 16.2% 씩 증가했습니다.
성장 가속화: 301267 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.
수익 대 산업: 301267 은 지난 1년 동안 마이너스 수익 성장( -21.4% )을 기록하여 Healthcare 업계 평균( -5.7% ).
자기자본 수익률
높은 ROE: 301267 의 자본 수익률 ( 9.1% )은 낮음 으로 간주됩니다.
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
